Literature DB >> 29032389

Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Moshe Frenkel1,2,3, Kenneth Sapire4.   

Abstract

Hematologic malignancies represent 9.7% of all cancers, making them the fourth most common type of cancer in the United States. The aggressive and complex treatments administered in hematologic malignancies result in a high burden of psychological needs. Complementary and integrative medicine (CIM) is becoming one of the options that patients use to address their distress during and after cancer treatments. It is not clear whether appropriate CIM can relieve distress in patients affected by these malignancies. This review covers the potential benefits of CIM as relates to nutrition, nutritional supplements, exercise, circadian rhythm, methods for reducing distress during bone marrow aspiration, massage therapy, and acupuncture, in treating patients with hematological malignancies. This review may provide a framework to enhance patient-doctor dialogue regarding CIM use in hematologic malignancies.

Entities:  

Keywords:  Acupuncture; Alternative medicine; Cancer care; Complementary medicine; Hematologic malignancies; Nutrition; Nutritional supplements

Mesh:

Year:  2017        PMID: 29032389     DOI: 10.1007/s11912-017-0635-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  131 in total

1.  Bioactive chemicals from carrot (Daucus carota) juice extracts for the treatment of leukemia.

Authors:  Rana Zaini; Malcolm R Clench; Christine L Le Maitre
Journal:  J Med Food       Date:  2011-08-24       Impact factor: 2.786

2.  Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners.

Authors:  Alex Molassiotis; Barbara Wilson; Susan Blair; Tracy Howe; James Cavet
Journal:  Psychooncology       Date:  2011-01       Impact factor: 3.894

3.  Systematic light exposure in the treatment of cancer-related fatigue: a preliminary study.

Authors:  William H Redd; Heiddis Valdimarsdottir; Lisa M Wu; Gary Winkel; Emily E Byrne; Melba A Beltre; Elizabeth S Liebman; Tanya Erazo; Judy A Hayes; Luis Isola; Eileen Scigliano; Yeraz Meschian; Susan Lutgendorf; Sonia Ancoli-Israel
Journal:  Psychooncology       Date:  2014-05-02       Impact factor: 3.894

4.  Anti-cancer activity of withaferin A in B-cell lymphoma.

Authors:  M K McKenna; B W Gachuki; S S Alhakeem; K N Oben; V M Rangnekar; R C Gupta; S Bondada
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Clock-cancer connection in non-Hodgkin's lymphoma.

Authors:  Yong Zhu; Tongzhang Zheng
Journal:  Med Hypotheses       Date:  2007-11-01       Impact factor: 1.538

6.  Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report.

Authors:  Ting Bao; Ruixin Zhang; Ashraf Badros; Lixing Lao
Journal:  Pain Res Treat       Date:  2011-03-09

7.  Physical activity for cancer survivors: meta-analysis of randomised controlled trials.

Authors:  Daniel Y T Fong; Judy W C Ho; Bryant P H Hui; Antoinette M Lee; Duncan J Macfarlane; Sharron S K Leung; Ester Cerin; Wynnie Y Y Chan; Ivy P F Leung; Sharon H S Lam; Aliki J Taylor; Kar-keung Cheng
Journal:  BMJ       Date:  2012-01-30

Review 8.  Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies.

Authors:  Mareike Kelkel; Claus Jacob; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2010-10-12       Impact factor: 4.411

9.  Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women.

Authors:  Eva S Schernhammer; Kimberly A Bertrand; Brenda M Birmann; Laura Sampson; Walter C Willett; Diane Feskanich
Journal:  Am J Clin Nutr       Date:  2012-10-24       Impact factor: 8.472

Review 10.  Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research.

Authors:  Ryan Eckert; Jennifer Huberty; Krisstina Gowin; Ruben Mesa; Lisa Marks
Journal:  Integr Cancer Ther       Date:  2016-07-24       Impact factor: 3.279

View more
  2 in total

Review 1.  Emerging Role of Integrative Medicine in Hematologic Malignancies: a Literature Review and Update on Current Trends in Complementary Medical Practices in Hematologic Cancers.

Authors:  Onyemaechi N Okolo; Krisstina Gowin
Journal:  Curr Hematol Malig Rep       Date:  2019-08       Impact factor: 3.952

Review 2.  Cancer-Related Fatigue-Is There a Role for Complementary and Integrative Medicine?

Authors:  Adi David; David Hausner; Moshe Frenkel
Journal:  Curr Oncol Rep       Date:  2021-11-07       Impact factor: 5.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.